Physician profile
Jonathan Constantin
NPI 1184627291
$2,151.97
in general payments reported to CMS, 2019-2025
24 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $647 · 2020: $37.41 · 2021: $126 · 2022: $337 · 2023: $374 · 2024: $431 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $246.07 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $222.58 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $216.45 | 2019-2025 | Farxiga, Wainua |
| Astellas Pharma US INC | $194.26 | 2019 | |
| Abbott Laboratories | $165.03 | 2019-2024 | Gallant |
| Abiomed | $151.32 | 2023-2025 | Impella |
| Pfizer INC. | $130.78 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $123.99 | 2021-2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $115.74 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $92.71 | 2022 | |
| Amgen INC. | $91.27 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $68.02 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $57.28 | 2021-2022 | |
| Vital Connect, INC | $49.43 | 2022 | |
| Boston Scientific Corporation | $42.63 | 2020-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $29.51 | 2025 | Ozempic |
| Philips North America LLC | $28.55 | 2024 | (Ck4) Mcot |
| Bayer Healthcare Pharmaceuticals INC. | $28.14 | 2022 | |
| Cvrx, INC. | $20.99 | 2023 | Barostim Neo System |
| Lantheus Medical Imaging, INC. | $19.55 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.85 | 2019 | |
| Stryker Corporation | $14.69 | 2025 | Artix Mt |
| Medtronic, INC. | $14.59 | 2024 | Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Constantin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.